Co-treating opioid and alcohol use disorders in the United States, 1960–2026: A historical policy review in the glucagon-like peptide-1 (GLP-1) era

Drug and Alcohol Dependence Reports · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles